Vasiliki Mavridou

Ms. Vasiliki Mavridou


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
VMVasiliki Mavridou
Vasiliki Mavridou
MKMartin King
Martin King
STSotiria Tavoulari
Sotiria Tavoulari
JRJonathan J. Ruprecht
Jonathan J. Ruprecht
SPShane M. Palmer
Shane M. Palmer
EKEdmund R.S. Kunji
Edmund R.S. Kunji
Mitochondrial ADP/ATP carriers import ADP into the mitochondrial matrix and export ATP to the cytosol to fuel cellular processes. Structures of the inhibited cytoplasmic- and matrix-open states have confirmed an alternating access transport mechanism, but the molecular details of substrate binding remain unresolved. Here, we evaluate the role of the solvent-exposed residues of the translocation pathway in the process of substrate binding. We identify the main binding site, comprising three positively charged and a set of aliphatic and aromatic residues, which bind ADP and ATP in both states. Additionally, there are two pairs of asparagine/arginine residues on opposite sides of this site that are involved in substrate binding in a state-dependent manner. Thus, the substrates are directed through a series of binding poses, inducing the conformational changes of the carrier that lead to their translocation. The properties of this site explain the electrogenic and reversible nature of adenine nucleotide transport.

1 November 2024 in Science Advances
Verified
Journal Article
Open access
VMVasiliki Mavridou
Vasiliki Mavridou
MKMartin King
Martin King
ABAndre Bazzone
Andre Bazzone
RSRoger Springett
Roger Springett
EKEdmund R.S. Kunji
Edmund R.S. Kunji
The mitochondrial adenosine 5′-diphosphate (ADP)/adenosine 5′-triphosphate (ATP) carrier imports ADP into the mitochondrion and exports ATP to the cell. Here, we demonstrate that 3.3 positive charges are translocated with the negatively charged substrate in each transport step. They can be assigned to three positively charged residues of the central substrate-binding site and two asparagine/arginine pairs. In this way, the membrane potential stimulates not only the ATP 4− export step, as a net −0.7 charge is transported, but also the ADP 3− import step, as a net +0.3 charge is transported with the electric field. These positive charge movements also inhibit the import of ATP and export of ADP in the presence of a membrane potential, allowing these nucleotides to be maintained at high concentrations in the cytosol and mitochondrial matrix to drive the hydrolysis and synthesis of ATP, respectively. Thus, this is the mechanism by which the membrane potential drives adenine nucleotide exchange with high directional fluxes to fuel the cellular processes.

24 July 2025 in Biochemical Journal
Verified
Journal Article
Open access
EKEdmund R.S. Kunji
Edmund R.S. Kunji
VMVasiliki Mavridou
Vasiliki Mavridou
MKMartin King
Martin King
CCCamila Cimadamore-Werthein
Camila Cimadamore-Werthein
SBStephany Jaiquel Baron
Stephany Jaiquel Baron
JRJonathan J. Ruprecht
Jonathan J. Ruprecht
With 53 members, the SLC25 mitochondrial carriers form the largest solute carrier family in humans. They transport a wide variety of substrates across the mitochondrial inner membrane to generate chemical energy and to supply molecules and ions for growth and maintenance of cells. They are among the smallest transporters in nature, yet they translocate some of the largest molecules without proton leak. With one exception, they are monomeric and have an unusual three-fold pseudo-symmetric structure. These carriers also have a unique transport mechanism, which is facilitated by six structural elements, meaning that all transmembrane helices move separately, but in a co-ordinated way. In addition, there are three functional elements that are an integral part of the alternating access mechanism, which opens and closes the carrier to the mitochondrial matrix or the intermembrane space. The first is a matrix gate, comprising the matrix salt bridge network and glutamine braces on transmembrane helices H1, H3 and H5. The second is a cytoplasmic gate, containing the cytoplasmic salt bridge network and tyrosine braces on transmembrane helices H2, H4 and H6. The third functional element is a single central substrate-binding site, the access to which is controlled by the opening and closing of the two gates in an alternating way. The electrostatic properties of the binding site facilitate the exchange of charged substrates across the inner membrane in the presence of a high membrane potential. Here, we discuss the extraordinary features of mitochondrial carriers, providing new insights into one of the most complex and dynamic transport mechanisms in nature.

Verified
Journal Article
Open access
PDF file
MKMartin King
Martin King
STSotiria Tavoulari
Sotiria Tavoulari
VMVasiliki Mavridou
Vasiliki Mavridou
AKAlannah C. King
Alannah C. King
JMJohn Mifsud
John Mifsud
EKEdmund R.S. Kunji
Edmund R.S. Kunji
Cryptosporidiumparvum is a clinically important eukaryotic parasite that causes the disease cryptosporidiosis, which manifests with gastroenteritis-like symptoms. The protist has mitosomes, which are organelles of mitochondrial origin that have only been partially characterized. The genome encodes a highly reduced set of transport proteins of the SLC25 mitochondrial carrier family of unknown function. Here, we have studied the transport properties of one member of the C. parvum carrier family, demonstrating that it resembles the mitochondrial ADP/ATP carrier of eukaryotes. However, this carrier has a broader substrate specificity for nucleotides, transporting adenosine, thymidine, and uridine di- and triphosphates in contrast to its mitochondrial orthologues, which have a strict substrate specificity for ADP and ATP. Inspection of the putative translocation pathway highlights a cysteine residue, which is a serine in mitochondrial ADP/ATP carriers. When the serine residue is replaced by cysteine or larger hydrophobic residues in the yeast mitochondrial ADP/ATP carrier, the substrate specificity becomes broad, showing that this residue is important for nucleotide base selectivity in ADP/ATP carriers.

23 August 2023 in Fish and Shellfish Immunology Reports
Verified
Journal Article
Open access
Maria TourakiMaria Touraki
Maria Touraki
ACAnna Chanou
Anna Chanou
VMVasiliki Mavridou
Vasiliki Mavridou
VTVasiliki Tsertseli
Vasiliki Tsertseli
MTMaria Tsiridi
Maria Tsiridi
EPEmmanuel Panteris
Emmanuel Panteris
• Photobacterium damselae ssp. piscicida (Phdp) growth is inhibited by probiotics. • Phdp is virulent to Artemia inducing oxidative stress and ultrastructural damage. • Probiotics administration prior to infection ameliorates oxidative stress response. • Probiotics improve intestinal ultrastructure and survival of Artemia post infection.

17 June 2025 in bioRxiv
Verified
Preprint
Open access
JGJose Enrique Gonzalez-Prada
Jose Enrique Gonzalez-Prada
AHAlexander S. Haworth
Alexander S. Haworth
JBJacob I. Browne
Jacob I. Browne
SSSamantha Salvage
Samantha Salvage
NSNicola Secomandi
Nicola Secomandi
PMPaul S. Miller
Paul S. Miller
Background and Purpose: Peptide toxins isolated from animal venom are potent and selective modulators of ion channels, and promising therapeutic leads. Due to intricate disulphide bridge patterns, they are often challenging to produce in standard laboratory settings, which limits engineering approaches to manipulate their structure-function properties. Given the low cost, wide accessibility, and versatility of recombinant expression systems for protein production, we set out to establish a straightforward high-yield strategy across a broad panel of peptide toxins from snakes, spiders and scorpions. Experimental Approach: 13 toxin DNA sequences were genetically fused to the C-terminus of either bivalent or monovalent human IgG1 antibody fragment crystallisable (Fc) domain sequences and expressed recombinantly from mammalian Expi293F cells. Affinity-purified proteins were evaluated by SDS-PAGE and size-exclusion chromatography (SEC). Function was assessed by Ca 2+ flux assays on CN21 cells, or whole-cell electrophysiology on human embryonic kidney (HEK293T) cells, Chinese hamster ovary (CHO) cells, or dorsal root ganglion (DRG) neurons. Immunocytochemistry using HEK293T cells and mouse DRG neurons assessed Fc-toxin fusion binding. Key Results: Monovalent Fc-toxin fusions consistently yielded 1-6 mg of pure, non-proteolytically cleaved protein from 20-70 ml cultures for several toxin types, including three-finger toxins from snakes, inhibitory cystine knot (ICK) toxins from spiders, and α-toxins from scorpions, substantially surpassing the performance of unfused toxins or bivalent Fc-toxin fusions which gave low or no yield. Snake toxins targeting nicotinic acetylcholine receptors retained high single digit nanomolar inhibitory potency. Spider and scorpion toxins targeting the voltage-gated Na + channel Na v 1.7 retained pharmacological function and selectivity across a panel of five Na v subtypes, albeit with reduced potencies that did not exceed ∼70 nM. Conclusions and Implications: We present a strategy for straightforward robust production of pure, monodisperse, and functional animal venom-derived toxins. This lowers the barrier to toxin production in a standard laboratory setting for follow-on engineering purposes.